mRNA vaccine development for cholangiocarcinoma: a precise pipeline
Abstract Cholangiocarcinoma (CHOL) is one of the most aggressive tumors worldwide and cannot be effectively treated by conventional and novel treatments, including immune checkpoint blockade therapy. The mRNA vaccine-based immunotherapeutic strategy has attracted much attention for various diseases,...
Main Authors: | Tian-Yu Tang, Xing Huang, Gang Zhang, Ming-Hao Lu, Ting-Bo Liang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-07-01
|
Series: | Military Medical Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40779-022-00399-8 |
Similar Items
-
Identification of Tumor Antigens and Immune Subtypes of Malignant Mesothelioma for mRNA Vaccine Development
by: Shuhang Wang, et al.
Published: (2022-07-01) -
Identification of Tumor Antigens and Design of mRNA Vaccine for Colorectal Cancer Based on the Immune Subtype
by: Cong Liu, et al.
Published: (2022-01-01) -
Personalized pancreatic cancer therapy: from the perspective of mRNA vaccine
by: Xing Huang, et al.
Published: (2022-10-01) -
Identification of Novel Tumor Antigens and the Immune Landscapes of Bladder Cancer Patients for mRNA Vaccine Development
by: Guixin Wang, et al.
Published: (2022-06-01) -
Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine
by: Hua Zhong, et al.
Published: (2021-08-01)